These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12467644)

  • 1. Triplex-forming oligonucleotides as modulators of gene expression.
    Guntaka RV; Varma BR; Weber KT
    Int J Biochem Cell Biol; 2003 Jan; 35(1):22-31. PubMed ID: 12467644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triplex-forming oligonucleotides as potential tools for modulation of gene expression.
    Rogers FA; Lloyd JA; Glazer PM
    Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):319-26. PubMed ID: 16101484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
    Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
    Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
    Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling DNA Triplex Assembly: Mass Spectrometric Investigation of Modified Triplex Forming Oligonucleotides for Enhanced Gene Targeting.
    Chandrasegaran S; Klose JW; Pukala TL
    J Am Soc Mass Spectrom; 2024 Sep; 35(9):2056-2063. PubMed ID: 39088835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-mediated transcription elongation control using triplex-based padlock oligonucleotides.
    Bello-Roufaï M; Roulon T; Escudé C
    Chem Biol; 2004 Apr; 11(4):509-16. PubMed ID: 15123245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of RNA duplexes by chemically modified triplex-forming oligonucleotides.
    Zhou Y; Kierzek E; Loo ZP; Antonio M; Yau YH; Chuah YW; Geifman-Shochat S; Kierzek R; Chen G
    Nucleic Acids Res; 2013 Jul; 41(13):6664-73. PubMed ID: 23658228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triplex-induced recombination and repair in the pyrimidine motif.
    Kalish JM; Seidman MM; Weeks DL; Glazer PM
    Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
    Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
    Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription.
    Liu J; Xu R; Jin Y; Wang D
    Nucleic Acids Res; 2001 Feb; 29(3):783-91. PubMed ID: 11160902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triplex formation inhibits HER-2/neu transcription in vitro.
    Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
    J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triplex-forming oligonucleotides as an anti-gene technique for cancer therapy.
    Li C; Zhou Z; Ren C; Deng Y; Peng F; Wang Q; Zhang H; Jiang Y
    Front Pharmacol; 2022; 13():1007723. PubMed ID: 36618947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
    Rogers FA; Lloyd JA; Tiwari MK
    Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triplex forming oligonucleotides: sequence-specific tools for gene targeting.
    Knauert MP; Glazer PM
    Hum Mol Genet; 2001 Oct; 10(20):2243-51. PubMed ID: 11673407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides.
    Hélène C
    Anticancer Drug Des; 1991 Dec; 6(6):569-84. PubMed ID: 1772570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting neighbouring poly(purine.pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides.
    Xodo LE; Rathinavelan T; Quadrifoglio F; Manzini G; Yathindra N
    Eur J Biochem; 2001 Feb; 268(3):656-64. PubMed ID: 11168404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus.
    Maldonado R; Filarsky M; Grummt I; Längst G
    RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
    Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
    Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.